The Valley Desk

NCT03397706 · Interventional trial

Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies

Overall registry status Completed

Phase 1 · Phase 2

Conditions Epstein-Barr Virus-Associated Lymphoma, Lymphoproliferative Disorders

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov